Tominaga T, Inoue O, Suzuki K, Yamasaki T, Hirobe M
Faculty of Pharmaceutical Sciences, University of Tokyo, Japan.
Int J Rad Appl Instrum B. 1987;14(5):491-6. doi: 10.1016/0883-2897(87)90115-2.
The organ distribution and the metabolic fate of 13N[amide-13N]nicotinamide ([13N]NAM) were studied in order to evaluate its potential as a radiotracer. After administration, [13N]NAM is transported, mainly by simple diffusion, into the brain and heart, where part of the tracer is metabolized into hydrophilic compounds ([13N]NAD etc.) and trapped. A very high radioactivity is accumulated in the small intestine, probably due to bile duct excretion of the tracer and its metabolites. [13N]NAM was found to be a useful tracer for the study of the utilization of the vitamin, nicotinamide.